Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment.

[1]  P. E. Simonsen,et al.  A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  G. Weil,et al.  A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. , 1999, The American journal of tropical medicine and hygiene.

[3]  P. E. Simonsen,et al.  Comparative evaluation of three new tools for diagnosis of bancroftian filariasis based on detection of specific circulating antigens. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  P. E. Simonsen,et al.  Bancroftian filariasis in an irrigation project community in southern Ghana , 1999, Tropical medicine & international health : TM & IH.

[5]  M. Alpers,et al.  Absence of ivermectin-associated excess deaths. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  D. Meyrowitsch,et al.  Long-term effect of mass diethylcarbamazine chemotherapy on bancroftian filariasis, results at four years after start of treatment. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  G. Weil,et al.  Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  E. Michael,et al.  Global mapping of lymphatic filariasis. , 1997, Parasitology today.

[9]  D. Molyneux,et al.  Onchocerciasis control: Moving towards the millennium. , 1997, Parasitology today.

[10]  A. Hightower,et al.  Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. , 1997, The American journal of tropical medicine and hygiene.

[11]  A. Hightower,et al.  Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.

[12]  R. Reintjes,et al.  Deaths associated with ivermectin for scabies , 1997, The Lancet.

[13]  D. Bundy,et al.  Anthelmintics. A comparative review of their clinical pharmacology. , 1997, Drugs.

[14]  R. Barkwell,et al.  Deaths associated with ivermectin treatment of scabies , 1997, The Lancet.

[15]  J. Habbema,et al.  Ivermectin for the chemotherapy of bancroftian filariasis: a meta‐analysis of the effect of single treatment , 1997, Tropical medicine & international health : TM & IH.

[16]  L. Nicolas,et al.  Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. , 1997, The Journal of infectious diseases.

[17]  D. Meyrowitsch,et al.  Wuchereria bancrofti in Tanzania: microfilarial periodicity and effect of blood sampling time on microfilarial intensities , 1997, Tropical medicine & international health : TM & IH.

[18]  C. R. Horsburgh,et al.  Pathology of emerging infections , 1997 .

[19]  B. Duke,et al.  Strategies and tools for the control/elimination of lymphatic filariasis. , 1997, Bulletin of the World Health Organization.

[20]  P. E. Simonsen,et al.  Lymphatic filariasis on the coast of Ghana. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  G. Weil,et al.  Parasite antigenemia without microfilaremia in bancroftian filariasis. , 1996, The American journal of tropical medicine and hygiene.

[22]  D. Addiss,et al.  Ultrasonographic assessment of the adulticidal efficacy of repeat high‐dose ivermectin in bancroftian filariasis , 1996, Tropical medicine & international health : TM & IH.

[23]  A. Georges,et al.  Current knowledge on the epidemiology, diagnosis, immunology, and treatment of loiasis. , 1995, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[24]  D. Freedman,et al.  Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. , 1995, The American journal of tropical medicine and hygiene.

[25]  H. Gilles,et al.  Diethylcarbamazine in the treatment of patients with onchocerciasis. , 1992, British journal of clinical pharmacology.

[26]  G. Weil,et al.  Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin. , 1991, The Journal of infectious diseases.

[27]  K. Goa,et al.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. , 1991, Drugs.

[28]  S. More,et al.  A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. , 1990, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.